A Novel Vitamin D Receptor Agonist, VS-105, Improves Bone Mineral Density without Affecting Serum Calcium in a Postmenopausal Osteoporosis Rat Model

BACKGROUND AND OBJECTIVES: VS-105, a novel vitamin D receptor agonist with significantly less hypercalcemic side effects than calcitriol, is a useful tool to investigate whether or not a vitamin D receptor agonist at non-hypercalcemic doses could improve bone mineral density (BMD). METHODS: VS-105 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu-Wong, J. Ruth, Wessale, Jerry L., Chen, Yung-Wu, Chen, Theresa, Oubaidin, Maysaa, Atsawasuwan, Phimon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478347/
https://www.ncbi.nlm.nih.gov/pubmed/34589670
http://dx.doi.org/10.14218/jerp.2020.00020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478347/
https://www.ncbi.nlm.nih.gov/pubmed/34589670
http://dx.doi.org/10.14218/jerp.2020.00020

Ejemplares similares